Cambridge Personal Genomics Limited in Cambridge, CB24 3AH

Description

Data updated on: 01-11-2023

Situated at 9 Station Road, Cambridge CB24 3AH Cambridge Personal Genomics Limited is classified as a Private Limited Company with 05968050 registration number. This firm was founded 18 years ago. Since October 4, 2007 Cambridge Personal Genomics Limited is no longer under the business name Cgen Consultancy Services. This company's declared SIC number is 72110, that means Research and experimental development on biotechnology. The company's most recent annual accounts describe the period up to Monday 31st October 2022 and the most current confirmation statement was filed on Wednesday 2nd November 2022.

The data at our disposal describing this specific company's members shows there are two directors: Matthew F. and Thomas B. who were appointed on September 26, 2007 and October 16, 2006. In order to find professional help with legal documentation, this particular firm has been utilizing the skills of Matthew F. as a secretary for the last 17 years.

Previous company's names
Cambridge Personal Genomics Limited 2007-10-04
Cgen Consultancy Services Limited 2006-10-16

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-10-31	2012-10-31	2013-10-31	2014-10-31	2015-10-31	2016-10-31	2017-10-31	2018-10-31	2019-10-31	2020-10-31	2021-10-31	2022-10-31	2023-10-31
Currency
Net Worth	624	606	596	585	575	564

Balance Sheet
Current Assets	508	455	455	455	455	455	455	2 263	3 433	5 139	4 431	2 017	3 662
Net Assets Liabilities						390	390	1 802	3 361	4 736	4 333	1 906	3 662
Cash Bank In Hand	508	455	455	455	455	455
Intangible Fixed Assets	159	164	167	169	172	174
Net Assets Liabilities Including Pension Asset Liability	624	606	596	585	575	564
Tangible Fixed Assets	10

Capital & Reserves
Called Up Share Capital	1 255	1 255	1 255	1 255	1 255	1 255
Profit Loss Account Reserve	-631	-649	-659	-670	-680	-691
Shareholder Funds	624	606	596	585	575	564

Other Financial Data
Creditors						65	65	461	72	403	98	111
Net Current Assets Liabilities	508	442	429	416	403	390	390	1 802	3 361	4 736	4 333	1 906	3 662
Other Operating Expenses Format2								13	85	48	78	2 428	13
Profit Loss								1 412	1 347	1 382	-78	-2 428	1 756
Staff Costs Employee Benefits Expense								300
Tax Tax Credit On Profit Or Loss On Ordinary Activities								104	317	324
Total Assets Less Current Liabilities	677	606	596	585	575	564	390	1 802	3 361	4 736	4 333	1 906	3 662
Turnover Revenue								1 725	1 748	1 754			1 769
Creditors Due After One Year	53
Creditors Due Within One Year		13	26	39	52	65
Fixed Assets	169	164	167	169	172	174
Intangible Fixed Assets Additions		5	3	2	3	2
Intangible Fixed Assets Cost Or Valuation	159	164	167	169	172	174
Secured Debts		13
Tangible Fixed Assets Cost Or Valuation	475	475
Tangible Fixed Assets Depreciation	465	475
Tangible Fixed Assets Depreciation Charged In Period		10
Amount Specific Advance Or Credit Directors	53	13

Company staff

Matthew F.

Role: Director

Appointed: 26 September 2007

Latest update: 4 March 2024

Matthew F.

Role: Secretary

Appointed: 26 September 2007

Latest update: 4 March 2024

Thomas B.

Role: Director

Appointed: 16 October 2006

Latest update: 4 March 2024

People with significant control

Executives with significant control over the firm are: Thomas B. owns over 1/2 to 3/4 of company shares . Matthew F. owns 1/2 or less of company shares.

Thomas B.

Notified on 6 April 2016

Nature of control:

over 1/2 to 3/4 of shares

Matthew F.

Notified on 6 April 2016

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 July 2024
Account last made up date	31 October 2022
Confirmation statement next due date	16 November 2023
Confirmation statement last made up date	02 November 2022

Annual Accounts 24 May 2013
Start Date For Period Covered By Report	2011-11-01
End Date For Period Covered By Report	2012-10-31
Date Approval Accounts	24 May 2013
Annual Accounts 28 December 2013
Start Date For Period Covered By Report	2012-11-01
End Date For Period Covered By Report	2013-10-31
Date Approval Accounts	28 December 2013
Annual Accounts 30 November 2014
Start Date For Period Covered By Report	2013-11-01
End Date For Period Covered By Report	2014-10-31
Date Approval Accounts	30 November 2014
Annual Accounts 25 April 2016
Start Date For Period Covered By Report	2014-11-01
End Date For Period Covered By Report	2015-10-31
Date Approval Accounts	25 April 2016
Annual Accounts 8 November 2016
Start Date For Period Covered By Report	2015-11-01
End Date For Period Covered By Report	2016-10-31
Date Approval Accounts	8 November 2016
Annual Accounts
Start Date For Period Covered By Report	01 November 2016
End Date For Period Covered By Report	31 October 2017
Annual Accounts
Start Date For Period Covered By Report	01 November 2017
End Date For Period Covered By Report	31 October 2018
Annual Accounts
Start Date For Period Covered By Report	01 November 2018
End Date For Period Covered By Report	31 October 2019
Annual Accounts
Start Date For Period Covered By Report	01 November 2019
End Date For Period Covered By Report	31 October 2020
Annual Accounts
Start Date For Period Covered By Report	01 November 2020
End Date For Period Covered By Report	31 October 2021
Annual Accounts
Start Date For Period Covered By Report	01 November 2020
End Date For Period Covered By Report	31 October 2021
Annual Accounts
Start Date For Period Covered By Report	01 November 2022
End Date For Period Covered By Report	31 October 2023

Cambridge Personal Genomics Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Matthew F.

Matthew F.

Thomas B.

Paul C.

Paul C.

People with significant control

Thomas B.

Matthew F.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies